Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
about
Can we use methylation markers as diagnostic and prognostic indicators for bladder cancer?Genetic and Epigenetic Alterations in Bladder CancerPrognostic significance of the methylation of Wnt pathway antagonists-CXXC4, DACT2, and the inhibitors of sonic hedgehog signaling-ZIC1, ZIC4, and HHIP in head and neck squamous cell carcinomas.Genome-wide DNA methylation profiling integrated with gene expression profiling identifies PAX9 as a novel prognostic marker in chronic lymphocytic leukemiaA global profile of gene promoter methylation in treatment-naïve urothelial cancerRenal cancer biomarkers: the promise of personalized careGenome-wide DNA methylation analysis predicts an epigenetic switch for GATA factor expression in endometriosis.Size-based enrichment of exfoliated tumor cells in urine increases the sensitivity for DNA-based detection of bladder cancer.Integrative epigenomic analysis of differential DNA methylation in urothelial carcinoma.Molecular subtypes of urothelial carcinoma are defined by specific gene regulatory systemsT-box 2 expression predicts poor prognosis in gastric cancer.Gene-expression analysis of gleason grade 3 tumor glands embedded in low- and high-risk prostate cancer.Bladder cancer: a simple model becomes complex.DNA methylation analyses of urothelial carcinoma reveal distinct epigenetic subtypes and an association between gene copy number and methylation statusNotI microarrays: novel epigenetic markers for early detection and prognosis of high grade serous ovarian cancer.Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.Management of T1 Urothelial Carcinoma of the Bladder: What Do We Know and What Do We Need To Know?The T-box transcription factor 3 is a promising biomarker and a key regulator of the oncogenic phenotype of a diverse range of sarcoma subtypesMoving forward in bladder cancer detection and diagnosis: the role of epigenetic biomarkers.DNA methylation-based biomarkers in bladder cancer.Nucleic acid-based biomarkers in body fluids of patients with urologic malignancies.Molecular biology of bladder cancer: new insights into pathogenesis and clinical diversity.Methylation markers for urine-based detection of bladder cancer: the next generation of urinary markers for diagnosis and surveillance of bladder cancer.On a FOX hunt: functions of FOX transcriptional regulators in bladder cancer.DNA Methylation and Urological Cancer, a Step Towards Personalized Medicine: Current and Future Prospects.Epigenetic changes as prognostic predictors in endometrial carcinomas.Protocadherin-17 promoter methylation in serum-derived DNA is associated with poor prognosis of bladder cancer.Methylated claudin-11 associated with metastasis and poor survival of colorectal cancer.Increased expression of TBX2 is a novel independent prognostic biomarker of a worse outcome in colorectal cancer patients after curative surgery and a potential therapeutic target.Integrative analysis of the epigenetic basis of muscle-invasive urothelial carcinoma.Clinicopathologic and Prognostic Significance of the Zinc Finger of the Cerebellum Family in Invasive Breast Cancer.DNA methylation in urothelial carcinoma.Clinical significance of protocadherin-8 (PCDH8) promoter methylation in bladder cancer.An integrated analysis of genome‐wide DNA methylation and gene expression data in hepatocellular carcinoma.The value of molecular markers in classification and prediction of progression in non-muscle-invasive bladder cancerStratification based on methylation of TBX2 and TBX3 into three molecular grades predicts progression in patients with pTa-bladder cancer
P2860
Q26744146-1F22A6E3-9039-47B3-BB70-3176E0671741Q28074732-8D3BB356-D9D3-44F9-8F55-BB36E0566623Q33720509-407F8E9A-35B8-4F55-9F0D-E5BF4F1C3251Q33742748-9276CDDB-EAE8-4CCC-BF2A-BC6C2B6D6243Q33779194-1283EB89-5A4F-43A9-8CC7-3D1383936813Q34422845-BC1D3392-946E-4B3B-B436-561E7E2FBE51Q35112893-7A9BB6B7-D480-4E60-BEBC-EB150118C341Q35147519-03C4CE66-06C4-490F-885D-21FF2CBD0E7DQ35215704-51F448C8-6B5C-4B3D-8B20-8F77E5381BFCQ35640830-69F41346-C7C2-4FB3-9B69-B3D70530070BQ35944332-A035FF16-F7A5-4BF0-BE5F-30DE4D007E4BQ36021088-FF1FE84A-1E80-4E10-8368-1A883A9C33B3Q36108115-9264C212-8038-4AE3-B5CB-38C8ECEF8375Q36187834-64CC0E7F-C58F-4914-BAD4-05A93751C15EQ36396570-2753848A-2ADF-4D94-BB00-C9B92E0F2962Q36557362-526CA1EB-DC7F-46EF-BE0D-0D08083EC08DQ37053829-7A5FF608-4C57-4AE9-A7C9-CC18D1A4E2D4Q37499273-6BE0D246-9DB9-4F11-B799-103CA665F7E4Q38068225-DEE80909-D7A5-4725-9594-809749436266Q38102879-DD998D05-1584-4E4E-85BE-566C78DEEFCDQ38216129-94CD59A0-F22C-42DB-A0B3-3272EF2215AEQ38297729-A1EE109E-F1F6-42C6-831E-9EABEBF0F05BQ38566949-3CBA8733-FBBE-4872-A4EA-97A7A4E88A57Q38789453-E0086224-6CB9-44CC-896B-1DD3B4927515Q38833395-88270C8F-4C19-40C1-9028-36B888ACAB97Q40462424-2CE1E4CA-9DD7-417C-BC63-0DFA2CF497DDQ44288628-906C666E-CBD6-43FE-A4F7-92F2D642CE1CQ47128149-3B309B05-48AA-409E-BCDA-CA4A3BCC9C40Q47743734-DE2F3CD7-B58A-4B0D-8431-167183509C87Q49874623-19FE2C5E-AAD0-4C57-AB20-F00D97C7BBD3Q52599653-6802C196-1BFE-452A-BEA6-0674CF4346D7Q53691833-328D0468-B200-42EB-BD5A-FAAC9555F25EQ54264662-E4214B62-878E-4C28-8E9D-457E311E9047Q55453653-D8FE858C-F12F-4C2A-90AC-E5B93D743F1FQ58804629-5B0463E7-E5BA-42FC-800C-CA66686421DDQ58862326-91DECE86-8C8B-4414-AC9E-FAF13E4FD59E
P2860
Genome-wide analysis of CpG island methylation in bladder cancer identified TBX2, TBX3, GATA2, and ZIC4 as pTa-specific prognostic markers.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Genome-wide analysis of CpG is ...... a-specific prognostic markers.
@en
type
label
Genome-wide analysis of CpG is ...... a-specific prognostic markers.
@en
prefLabel
Genome-wide analysis of CpG is ...... a-specific prognostic markers.
@en
P2093
P1433
P1476
Genome-wide analysis of CpG is ...... a-specific prognostic markers.
@en
P2093
Angela A G van Tilborg
Chris H Bangma
Dominique J P M Stumpel
Ellen C Zwarthoff
Lucie C Kompier
Ronald W Stam
P304
P356
10.1016/J.EURURO.2012.01.011
P407
P577
2012-01-18T00:00:00Z